Esther van den Boom

Insider Reports History

Location
San Diego, CA
Signature
/s/ Paul Joseph Slattery, Attorney-in-Fact for Esther van den Boom
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Esther van den Boom:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tyra Biosciences, Inc. Chief Financial Officer Common Stock 121,897 $801,960 $6.58 15 Sep 2022 Direct
Tyra Biosciences, Inc. Chief Financial Officer Common Stock 118,645 $780,565 $6.58 15 Sep 2022 Indirect
Tyra Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 89,054 06 Sep 2022 Direct

Insider Reports Filed by Esther van den Boom

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BSLK Bolt Projects Holdings, Inc. 13 Aug 2024 0 $0 3 Director 15 Aug 2024, 16:31
TYRA Tyra Biosciences, Inc. 15 Sep 2022 1 +$11,120 4 Chief Financial Officer 19 Sep 2022, 18:17
TYRA Tyra Biosciences, Inc. 06 Sep 2022 3 +$15,346 4 Chief Financial Officer 08 Sep 2022, 17:53
TYRA Tyra Biosciences, Inc. 02 Nov 2021 3 $0 4 Chief Financial Officer 04 Nov 2021, 19:59
TYRA Tyra Biosciences, Inc. 17 Sep 2021 2 $0 4 Chief Financial Officer 17 Sep 2021, 16:44
TYRA Tyra Biosciences, Inc. 14 Sep 2021 0 $0 3 Chief Financial Officer 14 Sep 2021, 21:15